Pro Dynam Oral Powder 1 g Phenylbutazone Per Sachet

国家: 英国

语言: 英文

来源: VMD (Veterinary Medicines Directorate)

现在购买

下载 产品特点 (SPC)
06-02-2023

有效成分:

Phenylbutazone

可用日期:

Dechra Veterinary Products A/S

ATC代码:

QM01AA01

INN(国际名称):

Phenylbutazone

药物剂型:

Oral powder

处方类型:

POM-V - Prescription Only Medicine – Veterinarian

治疗组:

Horses

治疗领域:

Anti Inflammatory NSAID

授权状态:

Authorized

授权日期:

1994-04-13

产品特点

                                Revised: 30
th
April 2009
AN: 02557/2008
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Pro-Dynam Oral Powder, 1 g phenylbutazone per sachet
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Each 5g sachet contains phenylbutazone 1g
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
White Oral Powder
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is indicated for the treatment of musculo-skeletal
conditions where relief from pain
and a reduction in the associated inflammation is required e.g. in
lameness associated with
osteoarthritic conditions, bursitis, laminitis and soft tissue
inflammation, particularly where
continued mobility is considered desirable.
It is also of value in limiting post surgical inflammation, myositis
and other soft tissue
inflammation.
Pro-Dynam can be used as an anti-pyretic where this is considered
advisable e.g. in viral
respiratory infections.
4.3
CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredient.
Use is contra-indicated in animals suffering from cardiac, hepatic or
renal disease, where there
is the possibility of gastro-intestinal ulceration or bleeding or
where there is evidence of a blood
dyscrasia.
Do not administer other NSAIDs concurrently or within 24 hours of each
other.
4.4
SPECIAL WARNINGS
The clinical effects of phenylbutazone can be evident for at least
three days following cessation
of therapy. This should be borne in mind when examining horses for
soundness.
Some equestrian authorities regard phenylbutazone as a ‘prohibited
substance’ within their
rules.
Revised: 30
th
April 2009
AN: 02557/2008
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not exceed the stated dose as the therapeutic index of
phenylbutazone is low.
Use in any animal less than 6 weeks of age or in aged animals may
involve additional risk. If
such use cannot be avoided, animals may require careful clinical
management.
Avoid use in any
                                
                                阅读完整的文件
                                
                            

搜索与此产品相关的警报